Cargando…
Development of a Sensitive Bioassay for the Analysis of IGF-Related Activation of AKT/mTOR Signaling in Biological Matrices
The bioactivity of the IGF system is not a function of isolated hormone concentrations in a given biological matrix. Instead, the biological activities of IGFs are regulated by IGFBPs, IGFBP proteases, and inhibitors of IGFBP proteases. Therefore, assays based on IGF-related bioactivity may describe...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995968/ https://www.ncbi.nlm.nih.gov/pubmed/33668197 http://dx.doi.org/10.3390/cells10030482 |
_version_ | 1783670018344484864 |
---|---|
author | Walz, Michael Höflich, Christine Walz, Christina Ohde, Daniela Brenmoehl, Julia Sawitzky, Mandy Vernunft, Andreas Zettl, Uwe K. Holtze, Susanne Hildebrandt, Thomas B. Wolf, Eckhard Hoeflich, Andreas |
author_facet | Walz, Michael Höflich, Christine Walz, Christina Ohde, Daniela Brenmoehl, Julia Sawitzky, Mandy Vernunft, Andreas Zettl, Uwe K. Holtze, Susanne Hildebrandt, Thomas B. Wolf, Eckhard Hoeflich, Andreas |
author_sort | Walz, Michael |
collection | PubMed |
description | The bioactivity of the IGF system is not a function of isolated hormone concentrations in a given biological matrix. Instead, the biological activities of IGFs are regulated by IGFBPs, IGFBP proteases, and inhibitors of IGFBP proteases. Therefore, assays based on IGF-related bioactivity may describe functions of the complete IGF system in a given biological matrix. Of particular interest are the IGF system effects on the AKT/mTOR pathway, as a dominant system for controlling growth, metabolism, and aging. In order to improve the sensitivity of IGF-dependent bioactivity, we made use of the known short-term and enhancing effects of IGFBP2 on the intracellular PI3K pathway. As a specific readout of this pathway, and further as a marker of the mTOR pathway, we assessed the phosphorylation of AKT-Ser473. Preincubation using IGFBP2 enhanced IGF1-dependent AKT-Ser473 phosphorylation in our experimental system. The assay’s specificity was demonstrated by inhibition of IGF1 receptors outside or inside the cell, using antiserum or small molecule inhibitors, which reduced AKT phosphorylation in response to exogenous IGF1 (p < 0.05). The maximal response of AKT phosphorylation was recorded 15 to 60 min after the addition of IGF1 to cell monolayers (p < 0.001). In our cellular system, insulin induced AKT phosphorylation only at supra-physiological concentrations (µM). Using this novel assay, we identified the differential biological activity of the IGF system in AKT-Ser473 phosphorylation in serum (mouse, naked mole rat, and human), in cerebrospinal fluid (human), and in colostrum or mature milk samples (dairy cow). We have developed a sensitive and robust bioassay to assess the IGF-related activation of the AKT/mTOR pathway. The assay works efficiently and does not require expensive cell culture systems. By using capillary immuno-electrophoresis, the readout of IGF-related bioactivity is substantially accelerated, requiring a minimum of hands-on time. Importantly, the assay system is useful for studying IGF-related activity in the AKT/mTOR pathway in a broad range of biological matrices. |
format | Online Article Text |
id | pubmed-7995968 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-79959682021-03-27 Development of a Sensitive Bioassay for the Analysis of IGF-Related Activation of AKT/mTOR Signaling in Biological Matrices Walz, Michael Höflich, Christine Walz, Christina Ohde, Daniela Brenmoehl, Julia Sawitzky, Mandy Vernunft, Andreas Zettl, Uwe K. Holtze, Susanne Hildebrandt, Thomas B. Wolf, Eckhard Hoeflich, Andreas Cells Article The bioactivity of the IGF system is not a function of isolated hormone concentrations in a given biological matrix. Instead, the biological activities of IGFs are regulated by IGFBPs, IGFBP proteases, and inhibitors of IGFBP proteases. Therefore, assays based on IGF-related bioactivity may describe functions of the complete IGF system in a given biological matrix. Of particular interest are the IGF system effects on the AKT/mTOR pathway, as a dominant system for controlling growth, metabolism, and aging. In order to improve the sensitivity of IGF-dependent bioactivity, we made use of the known short-term and enhancing effects of IGFBP2 on the intracellular PI3K pathway. As a specific readout of this pathway, and further as a marker of the mTOR pathway, we assessed the phosphorylation of AKT-Ser473. Preincubation using IGFBP2 enhanced IGF1-dependent AKT-Ser473 phosphorylation in our experimental system. The assay’s specificity was demonstrated by inhibition of IGF1 receptors outside or inside the cell, using antiserum or small molecule inhibitors, which reduced AKT phosphorylation in response to exogenous IGF1 (p < 0.05). The maximal response of AKT phosphorylation was recorded 15 to 60 min after the addition of IGF1 to cell monolayers (p < 0.001). In our cellular system, insulin induced AKT phosphorylation only at supra-physiological concentrations (µM). Using this novel assay, we identified the differential biological activity of the IGF system in AKT-Ser473 phosphorylation in serum (mouse, naked mole rat, and human), in cerebrospinal fluid (human), and in colostrum or mature milk samples (dairy cow). We have developed a sensitive and robust bioassay to assess the IGF-related activation of the AKT/mTOR pathway. The assay works efficiently and does not require expensive cell culture systems. By using capillary immuno-electrophoresis, the readout of IGF-related bioactivity is substantially accelerated, requiring a minimum of hands-on time. Importantly, the assay system is useful for studying IGF-related activity in the AKT/mTOR pathway in a broad range of biological matrices. MDPI 2021-02-24 /pmc/articles/PMC7995968/ /pubmed/33668197 http://dx.doi.org/10.3390/cells10030482 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ). |
spellingShingle | Article Walz, Michael Höflich, Christine Walz, Christina Ohde, Daniela Brenmoehl, Julia Sawitzky, Mandy Vernunft, Andreas Zettl, Uwe K. Holtze, Susanne Hildebrandt, Thomas B. Wolf, Eckhard Hoeflich, Andreas Development of a Sensitive Bioassay for the Analysis of IGF-Related Activation of AKT/mTOR Signaling in Biological Matrices |
title | Development of a Sensitive Bioassay for the Analysis of IGF-Related Activation of AKT/mTOR Signaling in Biological Matrices |
title_full | Development of a Sensitive Bioassay for the Analysis of IGF-Related Activation of AKT/mTOR Signaling in Biological Matrices |
title_fullStr | Development of a Sensitive Bioassay for the Analysis of IGF-Related Activation of AKT/mTOR Signaling in Biological Matrices |
title_full_unstemmed | Development of a Sensitive Bioassay for the Analysis of IGF-Related Activation of AKT/mTOR Signaling in Biological Matrices |
title_short | Development of a Sensitive Bioassay for the Analysis of IGF-Related Activation of AKT/mTOR Signaling in Biological Matrices |
title_sort | development of a sensitive bioassay for the analysis of igf-related activation of akt/mtor signaling in biological matrices |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995968/ https://www.ncbi.nlm.nih.gov/pubmed/33668197 http://dx.doi.org/10.3390/cells10030482 |
work_keys_str_mv | AT walzmichael developmentofasensitivebioassayfortheanalysisofigfrelatedactivationofaktmtorsignalinginbiologicalmatrices AT hoflichchristine developmentofasensitivebioassayfortheanalysisofigfrelatedactivationofaktmtorsignalinginbiologicalmatrices AT walzchristina developmentofasensitivebioassayfortheanalysisofigfrelatedactivationofaktmtorsignalinginbiologicalmatrices AT ohdedaniela developmentofasensitivebioassayfortheanalysisofigfrelatedactivationofaktmtorsignalinginbiologicalmatrices AT brenmoehljulia developmentofasensitivebioassayfortheanalysisofigfrelatedactivationofaktmtorsignalinginbiologicalmatrices AT sawitzkymandy developmentofasensitivebioassayfortheanalysisofigfrelatedactivationofaktmtorsignalinginbiologicalmatrices AT vernunftandreas developmentofasensitivebioassayfortheanalysisofigfrelatedactivationofaktmtorsignalinginbiologicalmatrices AT zettluwek developmentofasensitivebioassayfortheanalysisofigfrelatedactivationofaktmtorsignalinginbiologicalmatrices AT holtzesusanne developmentofasensitivebioassayfortheanalysisofigfrelatedactivationofaktmtorsignalinginbiologicalmatrices AT hildebrandtthomasb developmentofasensitivebioassayfortheanalysisofigfrelatedactivationofaktmtorsignalinginbiologicalmatrices AT wolfeckhard developmentofasensitivebioassayfortheanalysisofigfrelatedactivationofaktmtorsignalinginbiologicalmatrices AT hoeflichandreas developmentofasensitivebioassayfortheanalysisofigfrelatedactivationofaktmtorsignalinginbiologicalmatrices |